This article reviews a presentation by Kathryn Aikin of DDMAC/FDA in which she disclosed preliminary
results from the FDA's Physician Survey, which looked at the impact of DTC
advertising on the doctor-patient relationship.
The survey profiled 250 GP's
and 250 specialists (dermatology, allergy/pulmonology, endocrinology, and
psychiatry) from a random sample of the AMA Physician Masterfile, which
includes a list of all U.S. medical school graduates.